CFRA raises Allstate stock rating to 'Strong Buy', target $230
CFRA analyst Catherine Seifert upgraded Allstate's stock rating from 'Buy' to 'Strong Buy', maintaining a price target of $230.00. Seifert's valuation of Allstate (NYSE: ALL) shares is based on a ...
Orthopedic Group with about 230 employees, joins Penn State Health
Lancaster Orthopedic Group signed an agreement with Penn State Health that took effect on Jan. 31. The practice’s three ...
Allstate: Improving Results But Lackluster Capital Returns (Rating Upgrade)
Allstate beat Q4 expectations with strong earnings and revenue growth. See why ALL stock is rated a hold due to concerns over auto exposure and capital returns.
Allstate (ALL) Gets a Hold from Wells Fargo
In a report released yesterday, Elyse Greenspan from Wells Fargo reiterated a Hold rating on Allstate (ALL – Research Report), with a price ...